Skip to main content
    S

    Scisparc Ltd (SPRC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.68
    -0.26 (-6.60%)

    Market Cap: $2.29M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Jul 29
    		$N/AN/AN/ABeat-
    Mar 25
    Reported Apr 24
    		$-6.20$0.00N/AMiss-312.0%
    Sep 24
    Reported Nov 4
    		$-1.70$0.00N/AMiss-13.0%
    Mar 21
    Reported Jun 30
    		$-0.70$0.00N/AMiss+95.0%
    Dec 20
    Reported Mar 31
    		$-0.70$0.00N/AMiss+95.0%
    Sep 20
    Reported Dec 31
    		$-1.50$0.00N/AMiss+91.6%
    Jun 20
    Reported Sep 30
    		$-1.50$0.00N/AMiss+91.6%
    Mar 20
    Reported Jun 30
    		$-14.00$0.00N/AMiss-139900.0%
    Dec 19
    Reported Mar 31
    		$-14.00$0.00N/AMiss-139900.0%
    Sep 19
    Reported Dec 31
    		$-17.91$0.00N/AMiss+54.0%
    Jun 19
    Reported Sep 30
    		$-17.91$0.00N/AMiss-179026.0%
    Mar 19
    Reported May 15
    		$-0.01$0.00N/AMiss+100.0%
    Sep 18
    Reported Nov 28
    		$-0.01$0.00N/AMiss+50.0%
    Jun 18
    Reported Sep 30
    		$-38.95$0.00N/AMiss-97264.0%
    Mar 18
    Reported Apr 30
    		$-0.01$0.00N/AMiss+100.0%
    Dec 17
    Reported Mar 31
    		$-28.00$0.00N/AMiss+0.0%
    Sep 17
    Reported Nov 4
    		$-0.02$0.00N/AMiss-
    Jun 17
    Reported Aug 10
    		$-0.04$0.00N/AMiss-
    Mar 17
    Reported Jun 4
    		$-84.00$0.00N/AMiss-
    Dec 16
    Reported Mar 31
    		$-28.00$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-1721.00%
    ROE-164.50%ROICN/A
    Financial Health
    Debt/Equity0.68xInterest CoverageN/A
    Current Ratio0.87xQuick Ratio0.86x
    Trading Statistics
    Beta2.55Avg Volume19.50K
    52-Week High$40.4152-Week Low$2.98

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.32
    SMA 20$4.56
    SMA 50$5.49
    SMA 200$6.27
    EMA 10$4.26
    EMA 20$4.56
    EMA 50$5.17
    EMA 200$10.34

    MACD

    Line: -0.38Signal: -0.34Hist: -0.04

    ADX

    ADX: 10.5+DI: 20.5-DI: 28.8

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down100.0
    PSAR$5.02

    Bollinger Bands

    Upper Band$5.36
    Lower Band$3.76
    %B Position3507%(Upper)
    Band Width-0.05

    RSI (14-Day)

    Neutral
    30.7

    Momentum Oscillators

    Stoch %K3.3
    Stoch %D7.9
    Williams %R-94.8
    ROC (10d)-22.0%
    Momentum-1.04
    CCI (20d)-211.6
    MFI (14d)30.1

    Volatility Measures

    ATR (14d)$0.39(10.7%)
    StdDev (20d)0.40
    Hist Vol81.9%(High)

    Volume Flow

    VWAP$3.74
    OBV313.4M
    AD Line231.9B
    CMF (20d)-0.008

    Volume Metrics

    Avg Vol (20d)20.3K
    Vol Ratio0.6x
    VWMA (20d)$4.82

    Pivot Points

    R3$4.38
    R2$4.28
    R1$4.11
    Pivot Point$4.00
    S1$3.83
    S2$3.73
    S3$3.56

    Advanced Oscillators

    TSI-26.13
    Ultimate Osc35.9
    KST-195.64

    Financial Data

    QuarterJun 2026Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Total Revenue$284,000$395,000$461,000$466,000$840,000$907,000$1.97M$1.35MN/AN/AN/A$1.07M
    Cost of Revenue$72,000$169,000$290,000$434,000$366,000$584,000$1.27M$322,000N/AN/A$21,000$32,000
    Gross Profit$212,000$226,000$171,000$32,000$474,000$323,000$705,000$1.02MN/AN/A$-21,000$1.04M
    Operating Expenses$5.10M$-176,000$9.32M$10.88M$-3,053,000$-3,525,000$3.77M$5.34MN/AN/A$4.79M$3.11M
    R&D$1.57M$1.16M$938,000$974,000$841,000$860,000$781,000$1.33M$0$0$1.47M$1.03M
    SG&A$3.06M$4.72M$0$1.74M$2.55M$2.45M$2.49M$2.47M$0$0$3.32M$2.08M
    Operating Income$-4,887,000$402,000$-9,151,000$-10,843,000$3.53M$3.85M$-2,967,000$-3,474,000N/AN/A$-4,813,000$-3,141,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.16M$7.14M$1.06M$30,000$272,000$178,000$877,000$1.11M$0$0$905,000$114,000
    Income Before Tax$-6,051,000$-3,152,000$-9,412,000$-3,812,000$-3,684,000$-2,942,000$-2,919,000$3.18M$0$0$-5,718,000$-3,139,000
    Income Tax Expense$0$0$0$-19,000$-5,000$9,000$13,000$14,000$7,000$7,000$41,000$100,000
    Net Income$-5,371,000$-2,851,000$-9,328,000$-2,842,000$-3,442,000$-2,242,000$-2,880,000$3.17MN/AN/A$-5,759,000$-3,139,000
    EBITDA$-4,797,000$447,000$-8,962,000$-3,666,000$-3,308,000$-2,582,000$-2,700,000$-3,347,000N/AN/A$-4,792,000$5.85M
    EBIT$-4,887,000$402,000$-9,151,000$-3,929,000$-3,527,000$-2,806,000$-2,967,000$-3,474,000$-1,737,000$-1,737,000$-4,813,000$5.82M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SPRC

    News

    No cash would flow to SciSparc (SPRC) under a proposed debt-for-shares conversion.

    SciSparc Ltd. (SPRC) has entered into an agreement with L.I.A Pure Capital Ltd. to convert $2,023,039.21 of outstanding principal and accrued interest into ordinary shares at a conversion price of $1.50 per share. This...

    Stock Titan•10/15/26•Neutral

    Drug developer SciSparc (SPRC) plans to evaluate AI companies and technologies.

    SciSparc Ltd. (SPRC) announced a strategic shift towards evaluating Agentic AI-powered technologies, particularly in cybersecurity and finance. The company aims to identify opportunities within this ecosystem...

    Stock Titan•10/15/26•Neutral

    Why Is SciSparc Stock Gaining Thursday?

    SciSparc stock (SPRC) surged over 18% on Thursday following the company's announcement of a strategic pivot towards agentic artificial intelligence technologies...

    TradingView•10/15/26•Bullish

    Why Is SciSparc Stock Gaining Thursday?

    SciSparc Ltd. (NASDAQ: SPRC) saw its stock jump over 18% on Thursday following the announcement of a strategic shift towards agentic artificial intelligence technologies...

    Benzinga•10/15/26•Bullish

    SPRC Stock Draws Traders After Psychedelic IP And Quantum Push

    SciSparc Ltd. (SPRC) stock surged by 17.72% following positive news regarding its psychedelic intellectual property and quantum computing advancements. The company, through its NeuroThera subsidiary...

    www.timothysykes.com•10/15/26•Somewhat-Bullish

    SPRC Valuation and Fair Value

    P/B
    0.5x
    See GNG's fair value

    SPRC Profitability: Margins, ROIC and FCF

    Operating margin
    -1721.0%
    Net margin
    0.0%
    ROE
    -164.5%

    SPRC Competitors

    CompanyTicker
    Virax Biolabs Group Limited Ordinary SharesVRAX
    Nuwellis IncNUWE
    Flora Growth CorpFLGC
    Im Cannabis CorpIMCC
    Elevai Labs, Inc. Common StockELAB
    Qualigen Therapeutics IncQLGN
    GeoVax Labs IncGOVX
    Clearside Biomedical IncCLSD

    Sector: Healthcare

    SPRC Bull Case vs Bear Case

    Bear case

    • SPRC beat EPS estimates in 0.0% of its last 8 reported quarters.
    • SPRC's quarterly revenue changed -38.4% year over year.

    SPRC Earnings: Beat Rate and Next Report

    Beat rate
    0 of 8 quarters (0.0%)

    Frequently Asked Questions About SPRC

    Does SPRC pay dividends?

    Scisparc Ltd (SPRC) does not currently pay a regular dividend.

    What is SPRC's market cap?

    Scisparc Ltd (SPRC) has a market capitalization of $2.29M with a current stock price of $3.68.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In